Table 2

HLA-DR frequencies in total PMR, PMR with and without distal manifestations, and healthy controls

	Controls (n=148)	PMR total (n=92)	p versus controls	PMR without distal manifestations^1-150 (n=62)	p versus controls	PMR with distal manifestations^1-150 (n=30)	p versus controls
DR1	17.6	19.6	NS	19.4	NS	20	NS
DR15	12.2	12.0	NS	16.1	NS	3.3	NS
DR16	13.0	11.5	NS	12.9	NS	13.3	NS
DR3	12.8	22.8	0.05	19.4	NS	30.0	0.03
DR4	16.2	20.7	NS	19.4	NS	23.3	NS
DR11	33.8	45.7	NS	46.8	NS	43.3	NS
DR12	2.7	3.3	NS	1.6	NS	6.7	NS
DR13	27.7	17.4	NS	19.4	NS	13.3	NS
DR14	9.5	10.9	NS	11.3	NS	10	NS
DR7	26.4	18.5	NS	16.1	NS	23.3	NS
DR8	10.8	2.2	0.05	1.6	0.05	3.3	NS
DR9	2.0	0.0	NS	0.0	NS	0.0	NS
DR10	1.4	3.3	NS	3.2	NS	3.3	NS
Epitope 70-74	24.3	30.4	NS	29.9	NS	32.3	NS

↵1-150 Distal manifestations included the presence of peripheral synovitis and/or distal pitting oedema. Data shown as percentages.